X

Stay Connected

Sign Up for Updates

 
We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

New report shows 3 in 10 Americans that have insurance still face a financial barrier to care

By Katie Koziara  |    October 7, 2021
Today, we released the results in the first report in a series on patient experiences with the health care system. The report, titled “Barriers to Health Care Access in the Patient Experience,”...   Read More

Industry leaders discuss the impact of the drug pricing debate

By Brian Newell  |    September 23, 2021
This month, PhRMA hosted a media briefing with leaders within the biopharmaceutical industry to discuss the dangers of current proposals on government price setting, while also sharing alternative...   Read More

Five reasons tying VA prices to Medicare Part D misses the mark

By Nicole Longo  |    September 22, 2021
Some members of Congress are considering a government “negotiation” plan that would tie medicine prices in Medicare to those in the U.S. Department of Veterans Affairs (VA). This misguided...   Read More

America’s biopharmaceutical companies to Congress: Government “negotiation” is the wrong approach

By Stephen J. Ubl  |    September 15, 2021
Today, PhRMA member companies made public an open letter to Capitol Hill to encourage Congress to abandon old partisan ideas on drug pricing and instead pursue policies that actually address what...   Read More

ICYMI: Event spotlights how we can make Medicare work better for patients

By Katie Koziara  |    August 4, 2021
Last month, PhRMA sponsored “Making Medicare Work Better for Patients,” an event hosted by The Hill. During the event, policymakers, patient advocates and biopharmaceutical leaders spoke about how...   Read More

The future of the rebate rule: Will policymakers stand with patients?

By Stephen J. Ubl  |    August 2, 2021
Policymakers will soon decide whether to stand by new Medicare changes that will help lower costs for beneficiaries at the pharmacy counter or abandon these changes to fund government programs...   Read More

Celebrating Medicare’s 56th anniversary

By Gabby Migliara  |    July 30, 2021
For 56 years, Medicare has helped pay for medical care for Americans over the age of 65, as well as younger Americans with certain medical needs. Today marks Medicare’s anniversary and to...   Read More

Ask About Adherence: 3 factors impacting medication adherence for patients with diabetes and how our proactive affordability solutions can help

By Emilie Signora  |    July 20, 2021
Earlier this year, PhRMA released a proactive agenda with common-sense, patient-centered reforms to improve access to quality, affordable health care. The urgency of building a stronger, more...   Read More

New reports shed light on key facts about medicines and affordability

By Brian Newell  |    June 8, 2021
A recently released report by IQVIA – an independent organization specializing in health care research – provides new data showing prices for brand medicines went down last year. The report offers...   Read More

Out-of-pocket trends in Medicare Part D show rising costs for seniors

By Katie Koziara  |    May 24, 2021
A new study based on IQVIA data shows alarming trends in rising out-of-pocket costs for brand medicines among Medicare Part D beneficiaries with serious and complex conditions like cancer, HIV and...   Read More

Search the Catalyst

View Posts by Topic

see all

View Posts by Contributor

View Posts by Date

see all

Subscribe to Email Updates